1. Home
  2. ADPT vs THR Comparison

ADPT vs THR Comparison

Compare ADPT & THR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADPT
  • THR
  • Stock Information
  • Founded
  • ADPT 2009
  • THR 1954
  • Country
  • ADPT United States
  • THR United States
  • Employees
  • ADPT N/A
  • THR N/A
  • Industry
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • THR Industrial Machinery/Components
  • Sector
  • ADPT Health Care
  • THR Energy
  • Exchange
  • ADPT Nasdaq
  • THR Nasdaq
  • Market Cap
  • ADPT 929.8M
  • THR 960.7M
  • IPO Year
  • ADPT 2019
  • THR 2011
  • Fundamental
  • Price
  • ADPT $5.94
  • THR $31.00
  • Analyst Decision
  • ADPT Buy
  • THR Strong Buy
  • Analyst Count
  • ADPT 4
  • THR 1
  • Target Price
  • ADPT $6.75
  • THR $38.00
  • AVG Volume (30 Days)
  • ADPT 1.4M
  • THR 198.9K
  • Earning Date
  • ADPT 02-12-2025
  • THR 01-30-2025
  • Dividend Yield
  • ADPT N/A
  • THR N/A
  • EPS Growth
  • ADPT N/A
  • THR 4.78
  • EPS
  • ADPT N/A
  • THR 1.29
  • Revenue
  • ADPT $177,282,000.00
  • THR $493,855,000.00
  • Revenue This Year
  • ADPT $6.48
  • THR $2.25
  • Revenue Next Year
  • ADPT $18.84
  • THR $8.83
  • P/E Ratio
  • ADPT N/A
  • THR $23.72
  • Revenue Growth
  • ADPT N/A
  • THR 3.94
  • 52 Week Low
  • ADPT $2.28
  • THR $23.76
  • 52 Week High
  • ADPT $7.07
  • THR $35.93
  • Technical
  • Relative Strength Index (RSI)
  • ADPT 61.49
  • THR 49.45
  • Support Level
  • ADPT $5.98
  • THR $30.60
  • Resistance Level
  • ADPT $6.93
  • THR $33.25
  • Average True Range (ATR)
  • ADPT 0.45
  • THR 0.88
  • MACD
  • ADPT 0.03
  • THR -0.24
  • Stochastic Oscillator
  • ADPT 75.53
  • THR 14.15

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

About THR Thermon Group Holdings Inc.

Thermon Group Holdings Inc is a United States-based company that provides engineered thermal solutions for process industries. The company's product portfolio comprises electric heat tracing cables, steam tracing components, tubing bundles, and instrument and control products, as well as complementary product lines. It also provides turnkey services and design and engineering services. The company's customers include large engineering, procurement, and construction companies; oil and gas companies; commercial subcontractors; electrical component distributors; and others. The company has a presence, with the United States, Canada, and Europe being its top three markets and contributing the majority of its sales.

Share on Social Networks: